featured
Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed Multiple Myeloma Categorised by Age
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed Multiple Myeloma Categorised by Age: Secondary Analysis From the Phase 3 ASPIRE Study
Br. J. Haematol 2017 Feb 17;[EPub Ahead of Print], MA Dimopoulos, AK Stewart, T Masszi, I Špička, A Oriol, R Hájek, L Rosiñol, D Siegel, GG Mihaylov, V Goranova-Marinova, P Rajnics, A Suvorov, R Niesvizky, A Jakubowiak, J San-Miguel, H Ludwig, A Palumbo, M Obreja, S Aggarwal, P MoreauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.